Much evidence from epidemiological, migration, intervention, animal and genetic studies suggests that salt intake plays an important role in regulating blood pressure (BP). At the same time, many clinical trials have shown that reducing salt intake lowers BP. However, the magnitude of the fall in BP for a given reduction in salt intake varies with age, ethnic group and BP levels. This difference has been suggested to be related to the responsiveness of the reninangiotensin system (RAS). However, the sympathetic nervous system, the kallikrein-kinin system, the nitric oxide system, and many eicosanoids may also play a role. In this article, we address the important role of the RAS in determining the fall in BP with salt reduction.
Introduction
Much evidence from epidemiological, migration, intervention, animal and genetic studies suggests that salt intake plays an important role in regulating blood pressure (BP), 1 while at the same time many clinical trials have shown that reducing salt intake lowers BP. 2 However, the magnitude of the fall in BP for a given reduction in salt intake varies with age, ethnic group and BP levels. [3] [4] [5] For instance, with a similar reduction in salt intake, the elderly show a greater fall in BP compared with younger individuals, people of African origin have a greater fall compared with Caucasians, 4 and patients with high BP demonstrate a larger reduction compared with normotensives. 3 The mechanisms for these differences in BP response to salt reduction are not fully understood. It has been suggested that the responsiveness of the reninangiotensin system (RAS) plays an important role, 6 but the sympathetic nervous system, 7, 8 the kallikrein-kinin system, 9 the nitric oxide system, 10 and many eicosanoids 11 may also contribute. However, the evidence for many of these is circumstantial, whereas the evidence for the important role of the RAS is substantial and compelling.
The RAS is a normal mechanism for maintaining BP 12 and plays a very important role in stabilising BP levels when extracellular volume is changed. 6 For instance, when salt intake is reduced, extracellular volume decreases, but there are only small falls in BP. In other words, the increase in the activity of the RAS prevents the much larger falls in BP that would otherwise occur. The opposite occurs with salt loading, during which the RAS is suppressed; the rise in BP is therefore only small when there is an increase in extracellular volume. Many studies have shown that the fall in BP with salt reduction is significantly related to the degree of activation of the RAS, i.e. the greater the rise in plasma renin activity (PRA), and therefore angiotensin II (Ang II) and aldosterone, the smaller the fall in BP. [3] [4] [5] [13] [14] [15] [16] When the RAS is blocked by an angiotensin-convertingenzyme (ACE) inhibitor, BP becomes much more dependent on sodium and water balance, and changes in salt intake have much larger effects on BP. 17 In people of African origin, in whom the RAS is often suppressed unless reactive, salt reduction causes larger falls in BP. 4 In this article, we review the evidence for the role of the RAS in determining the changes in BP with changes in salt intake.
Studies in animals
DeClue et al. in 1978, demonstrated that chronic sodium chloride infusion in normal dogs caused very little change in BP. However, in dogs infused with low doses of Ang II (doses too small to cause an observable immediate increase in BP), the same sodium chloride infusion caused a large increase in BP. 18 These results suggested that if the RAS was not suppressed during chronic salt loading, large increases in BP would occur.
To further study the role of the RAS in determining the changes in BP with the changes in salt intake, Hall et al. performed an experiment of changing from a very low to a very high salt intake in: 1) normal dogs; 2) dogs with a constant low dose infusion of Ang II, (i.e. circulating levels of Ang II were fixed during the increases in salt intake) and; 3) dogs with endogenous production of Ang II blocked by the ACE inhibitor (ACE-I), captopril. 19 The results showed that, in normal dogs, an increase in salt intake from 5 mmol/day to 75, and 245 mmol/day caused no significant change in arterial pressure. A further increase in salt intake to 495 mmol/day caused only a very small increase in arterial pressure ( Figure 1 ). With the constant infusion of low levels of Ang II, the same increases in salt intake caused large increases in arterial pressure.These results confirmed the findings by DeClue et al. 18 that RAS suppression is an important means of preventing large increases in BP when salt intake is increased above usual levels. Furthermore, this study demonstrated that, with the infusion of captopril, there were large changes in BP with the changes in salt intake; there was a particularly large fall in BP when salt intake was below usual levels.These observations indicate that the RAS plays a major role in stabilising 
Studies in humans Patients on maintenance haemodialysis
In patients with end-stage renal disease (ESRD) on maintenance haemodialysis, there are large increases in extracellular volume between dialyses and large reductions during dialyses. Studies of BP control in these patients have shown the great importance of the RAS in determining the BP responses to these changes in extracellular volume. 23 For instance, in patients in whom large amounts of fluid are removed with little change in the RAS, large falls in BP occur. Indeed, BP can often be controlled in many patients on maintenance haemodialysis by sufficient removal of extracellular volume and a reduction in body weight. However, in patients who have large increases in RAS activity with a reduction in extracellular volume, BP falls much less or may even increase. By measuring blood volume, extracellular fluid volume, and PRA before and immediately after a dialysis, and by administering substances that nullify the pressor effect of Ang II, it is possible to show that hypertension in patients on maintenance haemodialysis is either volume-dependent, Ang II dependent, or sometimes a combination of both. 23 Figure 2 illustrates the findings in a patient whose BP was volume-dependent. Before dialysis, when the BP was 200/100 mmHg, the blood volume was obviously high, and there was a gross expansion of extracellular water, while PRA was abnormally low; the lack of effect of an intravenous infusion of saralasin (a competitor of Ang II) on BP indicated that, in this case, the BP was not dependent on the plasma level of Ang II.After several dialyses, the patient lost 9.5 kg of weight, BP fell to 128/78 mmHg, the blood volume, extra-cellular water, and PRA became normal, and the saralasin infusion again demonstrated that the BP was not dependent on Ang II. Figure 3 illustrates the findings in a patient whose BP was dependent on a raised level of Ang II. Before dialysis, when the BP was 180/100 mmHg, the blood volume was normal, though the extracellular water was 2.5 kg greater than predicted (a not unusual gain in weight between dialyses), PRA was greatly elevated, and the fall in BP induced by the infusion of saralasin indicated that the BP was under the 12 
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Figure 1
Effects of changing salt intake on mean arterial pressure in control dogs, in dogs infused with captopril, or in dogs infused with angiotensin II (Ang II) ( influence of Ang II.After a dialysis, the patient lost a 'normal' amount of weight (2.2 kg), the BP fell to 170/95 mmHg, and the blood volume and extracellular water were still 'normal', but the PRA was extremely high, and the greater fall in BP induced by saralasin infusion indicated that the BP was even more dependent on Ang II. In anephric patients, who have no functioning RAS, with no detectable levels of circulating PRA and very low levels of aldosterone, BP is exquisitely sensitive to changes in extracellular volume. These patients also require a considerable increase in blood volume in order to maintain BP at the same level as dialysis patients with intact kidneys (Figure 4 ).
Blockade of the renin-angiotensin system
With the use of ACE-I we demonstrated, in 1980, the physiological role of the RAS in buffering the changes in extracellular fluid volume that occur when salt intake is altered. 24 In normotensive individuals, when the salt intake was changed from high (350 mmol/day) to usual (120 mmol/day) and low-salt (10 mmol/day), there was little overall change in BP. However, when captopril was given, there was a fall in BP both on the high, usual and low-salt diet. More importantly, the fall in BP on the low-salt intake was much greater than that on the high-salt diet, and also greater compared with that on usual salt intake ( Figure 5 ). This fitted in with the basal levels of plasma Ang II, which were much higher on the low-salt diet and were preventing large falls in BP with the reduction in salt intake. 24 A further study, using saralasin, has demon-strated more directly the importance of the response of the RAS in determining the BP fall that occurs with salt restriction. 25 Twenty-nine REVIEW 
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patients with essential hypertension were studied on the fifth day of a high-salt diet (approximately 350 mmol/day) and on the fifth day of a low-salt diet (approximately 10 mmol/day). An infusion of saralasin was given on the fifth day of the low-salt diet.The fall in BP with saralasin was inversely correlated with the fall in BP with salt restriction, thus indicating that: 1) the patients who had the biggest fall in BP with salt restriction had the smallest fall in BP with saralasin when salt restricted, and 2) those subjects that had very little change in BP with salt restriction, had a bigger fall in BP with saralasin when salt restricted.This provides direct evidence that the fall in BP with salt restriction is, at least in part, mediated by the reactivity of the RAS. As the RAS is an important mechanism in maintaining BP during the changes in salt intake, it is therefore not surprising that most salt reduction studies show no significant relationship between the fall in BP and the change in sodium balance. 15, 26, 27 However, when the RAS is blocked by an ACE-I, BP becomes dependent on sodium and water balance. This was shown by a well-controlled, double-blind study, in which 15 hypertensive patients, who were already on captopril treatment, were randomised either to a salt intake of 180 mmol/day or to a reduced salt intake of 80 mmol/day for four weeks. 17 There was a large fall in BP with salt reduction in these patients. More importantly, the fall in BP with salt reduction was significantly correlated with weight loss (an index of sodium balance or change in extracellular volume), as well as the reduction in urinary sodium excretion that occurred when the salt intake was reduced. 17 Furthermore, when the RAS is blocked by an ACE-I, salt reduction is more effective in lowering BP. A modest reduction in salt intake reduced BP by 13/9 mmHg in hypertensive patients who were already on captopril, 17 whereas a similar reduction in salt intake lowered BP by only 8/5 mmHg in patients who were not on any drugs. 26, 27 A further double-blind study has shown that a modest reduction in salt intake is as effective as a thiazide diuretic (hydrochlorothiazide 25 mg/day) when added to an ACE-I. 28 Importance of the renin-angiotensin system in determining the differences in blood pressure response to salt reduction Most investigators have reported that subjects who have a greater fall in BP with salt reduction have lower levels of PRA and, often, of plasma aldosterone concentrations. The implications of these observations may be two-fold. 29 First, the lower values of PRA may reflect a relative expansion of extracellular fluid volume. Thus, one would expect that the greater BP response to sodium and volume restriction would be likely in the volume-expanded subjects. An alternative explanation is that the RAS protects against sodium and volume depletion and maintains vascular homeostasis. Therefore, the subjects with relatively less RAS responsiveness would have a greater permissive fall in BP with the low-salt diet. Evidence in support of this was demonstrated in the study by Weinberger et al. in which they compared two different tests for the assessment of BP responses to sodium in the same individuals. 30 The increases in PRA with the sodium and water depletion induced by the low-salt diet and frusemide in the first study was closely correlated (p<0.001) with the BP response to the low-salt diet in the second study, which was conducted three months later.
In people of African origin, in whom there is suppression of the RAS, salt reduction is particularly effective in lowering BP. In a recent study, 4 we compared African-Caribbean and Caucasian hypertensive patients to study their differences in BP response to an acute and large reduction in salt intake (from approximately 350 mmol/day to 10 mmol/day) and to elucidate whether the RAS plays a role for these different BP responses. The results showed that, with a similar reduction in salt intake, the African-Caribbeans had a greater fall in BP, but a smaller increase in PRA and Ang II than the Caucasians (Figure 6 ). The fall in BP was significantly correlated with the rise in PRA and Ang II that occurred with salt reduction (Figure 7) . These results demonstrated that the larger fall in BP with salt reduction in the African-Caribbeans is, at least in part, due to their less responsive RAS. Luft et al. 31, 32 also observed that normotensive people of African origin had a larger increase in BP in response to saline infusion and a greater suppression of PRA 24 hours after saline infusion than did Caucasians.
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Figure 6
Changes in systolic blood pressure (SBP), plasma renin activity (PRA) and angiotensin II (Ang II) from the high-to low-salt diet in African-Caribbean and Caucasian hypertensive patients. *p<0.05 African-Caribbeans versus Caucasians adjusted for age and SBP on the usual diet. † p<0.01, † † p<0.001 compared to the highsalt diet. § p<0.05, § § p<0.001 African-Caribbeans versus Caucasians in the rises in PRA or Ang II from the high-to low-salt diet adjusted for age In patients with essential hypertension, the RAS is also suppressed, particularly as BP becomes more severe. In a separate study, 3 by comparing hypertensive and normotensive Caucasians, we have shown that with an acute and large reduction in salt intake, hypertensive individuals had a large fall in BP with a small rise in PRA, whereas age-and sex-matched normotensive individuals had little change in BP but a large compensatory increase in PRA and thereby,Ang II (Figure 8 ).The fall in BP was significantly correlated with the increases in PRA that occurred with salt reduction.These results demonstrate the importance of the RAS in determining the differences in BP response to salt reduction between hypertensive and normotensive individuals. Using rapid sodium and volume expansion (saline infusion) and contraction manoeuvres (low-salt diet and frusemide administration), Weinberger et al. 5 studied 378 normal volunteers and 198 patients with essential hypertension, and showed that the hypertensive patients had a larger fall in mean arterial pressure compared with the normotensives. They also found that subjects who showed a greater BP response to sodium depletion (i.e. more sodiumsensitive) had lower PRA at baseline and a smaller rise in PRA after sodium and volume depletion. In another study, Overlack et al. 33 investigated the BP responses to one week of low-sodium (20 mmol/day) and high-sodium intake (300 mmol/day) in 163 normotensive Caucasians. With the alteration of sodium intake, there was no significant change in the average BP, but individual BP responses were heterogeneous, and were related to the PRA at baseline, as well as during the low-and high-salt diets.
Conclusion
Substantial evidence suggests that the RAS plays an important role in determining the changes in BP in response to an alteration of salt intake. The reactive rise in PRA, and thereby, Ang II with salt reduction offsets the fall in BP that occurs with a low-salt diet.When the RAS is blocked by an ACE-I or Ang II antagonist, BP then becomes dependent on sodium and water balance, and salt reduction is therefore more effective in lowering BP. In people of African origin, the elderly, and those with hypertension, there is suppression of the RAS; hence reducing salt intake has a greater effect on BP in these individuals. A greater understanding of the physiology and pathophysiology of the RAS will lead to a much more rational usage of RAS blockers, such as ACE-Is, Ang II antagonists and aldosterone antagonists, in the treatment of hypertension and heart failure. 
